Gene polymorphisms of cyclin‐dependent kinase inhibitor and matrix metalloproteinase‐9 in Sudanese patients with esophageal squamous cell carcinoma

Gene polymorphisms of cyclin‐dependent kinase inhibitor and matrix metalloproteinase‐9 in Sudanese patients with esophageal squamous cell carcinoma

Abstract Background The polymorphisms of the cyclin‐dependent kinase inhibitor (CDKN1A) gene and matrix metalloproteinase‐9 (MMP9) gene may increase one's susceptibility to malignancies. In this study, the association of the single nucleotide polymorphisms (SNPs) CDKN1A rs1059234 c.70C>T at...

Full description

Bibliographic Details
Main Authors: Majdolin Mohammed Eltayeb, Mohamed M. Ali, Saeed M. Omar, Nouh Saad Mohamed, Ishag Adam, Hamdan Z. Hamdan
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
cyclin‐dependent kinase inhibitor (CDKN1A)
esophageal squamous cell carcinoma
matrix metalloproteinase 9 (MMP9)
single nucleotide polymorphism
Sudan
Online Access:https://doi.org/10.1002/mgg3.2074

Internet

https://doi.org/10.1002/mgg3.2074

Similar Items